Castle Biosciences, Inc. (NASDAQ:CSTL) Q4 2025 Earnings Call Transcript February 26, 2026
Castle Biosciences, Inc. beats earnings expectations. Reported EPS is $-0.08, expectations were $-0.23.
Operator: Good afternoon, and welcome to Castle Biosciences Fourth Quarter and Full Year 2025 Conference Call. As a reminder, today’s call is being recorded. We will begin today’s call with opening remarks and introductions, followed by a question-and-answer session. I would like to turn the call over...
